Low and high infection dose transmissions of SARS-CoV-2 in the first COVID-19 clusters 1 in Northern Germany 2

28 Objectives: We used viral genomics to deeply analyze the first SARS-CoV-2 infection clusters in the 29 metropolitan region of Hamburg, Germany. Epidemiological analysis and contact tracing together with 30 a thorough investigation of virus variant patterns revealed low and high infection dose transmissions to 31 be involved in transmission events. 32 Methods : Infection control measures were applied to follow up contract tracing. Metagenomic RNA- 33 and SARS-CoV-2 amplicon sequencing was performed from 25 clinical samples for sequence analysis 34 and variant calling. 35 Results: The index patient acquired SARS-CoV-2 in Italy and after his return to Hamburg transmitted 36 it to 2 out of 132 contacts. Virus genomics and variant pattern clearly confirms the initial local cluster. 37 We identify frequent single nucleotide polymorphisms at positions 241, 3037, 14408, 23403 and 28881 38 previously described in Italian sequences and now considered as one major genotype in Europe. While 39 the index patient showed a single nucleotide polymorphism only one variant was transmitted to the 40 recipients. Different to the initial cluster, we observed in household clusters occurring at the time in 41 Hamburg also intra-host viral species transmission events. 42 Conclusions: SARS-CoV-2 variant tracing highlights both, low infection dose transmissions suggestive 43 of fomites as route of infection in the initial cluster and high and low infection dose transmissions in 44 family clusters indicative of fomites and droplets as infection routes. This suggests (1) single viral 45 particle infection can be sufficient to initiate SARS-CoV-2 infection and (2) household/family members 46 are exposed to high virus loads and therefore have a high risk to acquire SARS-CoV-2. 47 48 49 50 51 52 53 54 55

[1]  Colin Renfrew,et al.  Phylogenetic network analysis of SARS-CoV-2 genomes , 2020, Proceedings of the National Academy of Sciences.

[2]  C. Eastin,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The Journal of Emergency Medicine.

[3]  Changchuan Yin Genotyping coronavirus SARS-CoV-2: methods and implications , 2020, Genomics.

[4]  Eric H. Y. Lau,et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.

[5]  MingKun Li,et al.  Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Xiang Li,et al.  On the origin and continuing evolution of SARS-CoV-2 , 2020, National science review.

[7]  Susanne Pfefferle,et al.  Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  S. Pascarella,et al.  COVID‐2019: The role of the nsp2 and nsp3 in its pathogenesis , 2020, Journal of medical virology.

[9]  Min Kang,et al.  SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.

[10]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[11]  Qun Li Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020 .

[12]  Heng Li,et al.  Minimap2: pairwise alignment for nucleotide sequences , 2017, Bioinform..

[13]  P. Wohlsein,et al.  Recovery of the first full-length genome sequence of a parapoxvirus directly from a clinical sample , 2017, Scientific Reports.

[14]  Yuelong Shu,et al.  GISAID: Global initiative on sharing all influenza data – from vision to reality , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  Stefan Elbe,et al.  Data, disease and diplomacy: GISAID's innovative contribution to global health , 2017, Global challenges.

[16]  M. Aepfelbacher,et al.  Evaluation of Unbiased Next-Generation Sequencing of RNA (RNA-seq) as a Diagnostic Method in Influenza Virus-Positive Respiratory Samples , 2015, Journal of Clinical Microbiology.

[17]  H. Rohde,et al.  Rapid Metagenomic Diagnostics for Suspected Outbreak of Severe Pneumonia , 2014, Emerging infectious diseases.

[18]  Jiajie Zhang,et al.  PEAR: a fast and accurate Illumina Paired-End reAd mergeR , 2013, Bioinform..

[19]  Gabor T. Marth,et al.  Haplotype-based variant detection from short-read sequencing , 2012, 1207.3907.

[20]  Christian Drosten,et al.  The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors , 2011, PLoS pathogens.

[21]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[22]  John R. Yates,et al.  Severe Acute Respiratory Syndrome Coronavirus Nonstructural Protein 2 Interacts with a Host Protein Complex Involved in Mitochondrial Biogenesis and Intracellular Signaling , 2009, Journal of Virology.

[23]  R. Baric,et al.  The nsp2 Replicase Proteins of Murine Hepatitis Virus and Severe Acute Respiratory Syndrome Coronavirus Are Dispensable for Viral Replication , 2005, Journal of Virology.